Preprint Brief Report Version 1 Preserved in Portico This version is not peer-reviewed

Does the esv3587290 Copy-Number Variation in the VANGL1 Gene Differ as a Genetic Factor for Developing Nephritis in Mexican versus European Childhood-Onset Systemic Lupus Erythematosus Patients?

Version 1 : Received: 30 April 2024 / Approved: 1 May 2024 / Online: 1 May 2024 (05:05:57 CEST)

How to cite: ALCÁNTARA-ORTIGOZA, M. A.; Rodríguez-Lozano, A. L.; Estandía-Ortega, B.; González-del Angel, A.; Díaz-García, L.; Rivas-Larrauri, F. E.; Nájera-Velázquez, R. G. Does the esv3587290 Copy-Number Variation in the VANGL1 Gene Differ as a Genetic Factor for Developing Nephritis in Mexican versus European Childhood-Onset Systemic Lupus Erythematosus Patients?. Preprints 2024, 2024050040. https://doi.org/10.20944/preprints202405.0040.v1 ALCÁNTARA-ORTIGOZA, M. A.; Rodríguez-Lozano, A. L.; Estandía-Ortega, B.; González-del Angel, A.; Díaz-García, L.; Rivas-Larrauri, F. E.; Nájera-Velázquez, R. G. Does the esv3587290 Copy-Number Variation in the VANGL1 Gene Differ as a Genetic Factor for Developing Nephritis in Mexican versus European Childhood-Onset Systemic Lupus Erythematosus Patients?. Preprints 2024, 2024050040. https://doi.org/10.20944/preprints202405.0040.v1

Abstract

A ~3-kb deletion-type DNA copy-number variation (CNV, esv3587290) located at intron 7 of the VANGL1 gene (1p13.1, MIM*610132) has been proposed as a genetic factor for developing lupus nephritis (LN) in adult systemic lupus erythematosus (SLE) patients across European-descent populations, but its replication in other ethnicities has been inconsistent and its association with LN in childhood-onset SLE (cSLE) remains unknown. Here, we performed an exploratory association study in a sample of 66 unrelated cSLE Mexican patients (11 males, 55 females; ages 7.8 to 18.6 years). Two stratified groups were compared: cSLE patients with (N=37) or without (N=29) LN, as diagnosed by renal biopsy (N=15), proteinuria (N=33), urinary protein:creatinine ratio >0.2 (N=34), and erythrocyturia and/or granular casts in urinary sediment (N=16). For esv3587290 CNV genotyping, we performed an end-point PCR assay with breakpoint confirmation by Sanger sequencing. We also determined the allelic frequencies of the esv3587290 CNV in 181 deidentified ethnically-matched individuals (reference group). The obtained genotypes were tested for Hardy-Weinberg equilibrium (HWE) by 2 test. Associations between LN and esv3587290 CNV were tested by calculating the Odds Ratio (OR) and using Pearson's 2 tests with a 95% confidence interval and p≤0.05. Contrary to the results described in European-descent populations, the esv3587290 CNV showed a significant protective effect against LN development (OR 0.14, 95% CI 0.066-0.31, p≤0.05), whereas the wild-type homozygous VANGL1 genotype showed a risk trend for LN development (OR 2.15, 95% CI 0.7711-6.18, p≤0.05). Finally, we characterized the precise breakpoint of the esv3587290 CNV as NG_016548.1(NM_138959.3):c.1314+1339_1315-897del (https://databases.lovd.nl/shared/variants/0000918418#00025811) in our population. This report supports the notion that a broad genetic heterogeneity underlies the susceptibility for developing LN.

Keywords

childhood-onset systemic lupus erythematosus; lupus nephritis; VANGL1 gene; DNA copy-number variation; Mexican population

Subject

Medicine and Pharmacology, Pediatrics, Perinatology and Child Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.